Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting

Laura E. Baldassari,Jenny Feng,Gabrielle Macaron,Sarah M. Planchon,Ebtesam Alshehri,Brandon P. Moss,Daniel Ontaneda,Mary A. Willis

Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting

2019

Laura E. Baldassari
Jenny Feng
Gabrielle Macaron
Sarah M. Planchon
Ebtesam Alshehri
Brandon P. Moss
Daniel Ontaneda
Mary A. Willis

BackgroundTuberculosis screening is recommended in multiple sclerosis patients starting certain disease-modifying therapies. Disease-modifying therapies may affect interferon-gamma release assay re...

Keywords:

Multiple sclerosis
Tuberculosis screening
Internal medicine
Disease
Indeterminate
Medicine
Risk assessment
tb screening

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations